Diversion
Description:
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source:
PCSS
Tags:
Description:
This 2010 Physician Clinical Support System (PCSS) document written by Dr. Judith Martin discusses types of aberrant behavior associated with buprenorphine and steps that can be taken to reduce the risk of abuse and diversion.
Source:
Physician Clinical Support System (PCSS)
Tags:
Description:
This is a list of each state's prescription monitoring program contact information.
Source:
National Association of State Controlled Substances Authorities (NASCSA) (3 votes)
Tags:
Description:
These FAQs address common questions regarding prescription drug monitoring programs.
Source:
Drug Enforcement Agency (DEA) (4 votes)
Description:
This is the NASPER website which includes various information on the $60 million dollar 2005 grant to help states start or improve state-run prescription monitoring programs (PMPs).
Source:
American Society of Interventional Pain Physicians (3 votes)
Tags:
Description:
This is New York State's Controlled Substances Act, which outlines all legal aspects involving controlled substances, including record keeping, storing, and dispensing.
Source:
New York State Health Department (4 votes)
Tags:
Description:
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source:
Drug Enforcement Agency (DEA) (3 votes)
Tags:
Description:
RADARS®, the Researched Abuse, Diversion, and Addiction-Related Surveillance System, tracks prescription drug abuse, misuse and diversion throughout the United States. It is a nonprofit operation of the Rocky Mountain Poison and Drug Center, a division of Denver Health.
Source:
RADARS® (3 votes)
Tags:
Description:
This presentation discusses diversion of Subutex® and Suboxone® both in a general sense and in the specific case of the RADARS system, a nonprofit governmental program through the Rocky Mountain Poison and Drug Center.
Source:
Nabarun Dasgupta, MPH (presentation from SAMHSA 2008 Buprenorphine Summit) (3 votes)
Tags:
Description:
This form helps clinics keep a record of the drugs given out to each patient. This particular form has sections for date, patient's name, patient ID, dose, quantity dispensed, balance, manufacturer number, and patient's signature.
Source:
American Academy of Addiction Psychiatry (AAAP) (3 votes)
Tags:
